Navigation Links
Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
Date:7/10/2008

cultural exhibits provide many possible routes of transmission for E. coli. Direct animal contact is the obvious route, but contact with contaminated products (e.g., sawdust, shavings, soiled clothing or shoes) can also lead to human infection.

The E. coli O157:H7 cattle vaccine will be manufactured in the Bioniche production facility in Belleville, Ontario, Canada where a two-year, $25 million expansion is taking place, supported by the Ontario and Canadian governments. Vaccine supply will be limited during this manufacturing expansion period.

About the E. coli O157:H7 Cattle Vaccine

This vaccine received international recognition in September, 2007 by the Animal Pharm Industry Excellence Awards as the best new veterinary product for livestock globally. The vaccine has been developed by a strategic alliance formed in 2000 between the University of British Columbia (UBC), the Alberta Research Council (ARC), the University of Saskatchewan's Vaccine & Infectious Disease Organization (VIDO), and Bioniche, which holds the rights for worldwide commercialization of the vaccine. The vaccine prevents the E. coli O157:H7 bacteria from attaching to the intestines of vaccinated cattle, thereby reducing their reproduction within the animal, and reducing the amount of bacteria that can be released through cattle manure in the environment. More than 30,000 cattle have been involved in clinical testing of the vaccine over the past five years.

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by r
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
2. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
3. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
4. Bioniche Presents Pre-Clinical Research at Two International Conferences
5. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
6. Bioniche Reports Fiscal 2008 Third Quarter
7. Bioniche Appoints U.S. President of Food Safety
8. Bioniche Reports the Passing of its Board Chair
9. Bioniche Converts a Portion of its Debt to Equity
10. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
11. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 According to a new ... (III-V, II-VI, IV-IV, sapphire), Deposition Technology (CVD, MBE, ... Opto-electronic), Application, and Geography-2013-2020", published by MarketsandMarkets, the ... of 12.63% from 2014 to 2020 and reach ... data tables and 88 figures spread through 342 ...
(Date:7/28/2014)... July 28, 2014 The Healthcare ... graduates of its Advanced Training Program in Healthcare ... roles in their health care organization ranging from ... methodology of continuous quality improvement in the health ... Dr. Brent James’ internationally recognized Advanced Training Program ...
(Date:7/28/2014)... 28, 2014 The Europe Carotenoids & ... antioxidants market in Europe with analysis and forecast of ... in 2012 to $765.93 million by 2018, at a ... through the TOC of the Europe Carotenoids & Antioxidants ... analysis provided. It also provides a glimpse of the ...
(Date:7/28/2014)... is proposing a new theory to explain why older ... necessarily show declines in the workplace or daily life. ... are to maintain focus on cognitive tasks. , "My ... we see in cognitive performance in different settings," says ... State and author of a paper describing the theory. ...
(Date:7/28/2014)... European project SOPHIE has evaluated the relationship between ... in health in Europe. The results show that ... Europe) and countries with contradictory policies (Eastern Europe), ... reported poorer health than men. Health inequalities are ... present a 27% higher risk of having poor ...
Breaking Medicine News(10 mins):Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Gender inequalities in health: A matter of policies 2
... Tenet Healthcare Corporation (NYSE: THC ) ... named to the company,s 2009 Circle of Excellence. ... of Excellence honors Tenet hospitals that have achieved ... performance. Key metrics used to evaluate the ...
... Life Well(SM)" Offers 10 Proven Tools to Combat Stress ... worries to family responsibilities, Americans are dealing with ever-increasing ... Mental Health America today launched an innovative public education ... stressful times. Called Live Your Life Well(SM) , ...
... Lung Cancer Alliance announced that a comprehensive ... high mortality rate was introduced with bipartisan support ... http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO )"We now ... approach to lung cancer in both Houses of ...
... Citizenship Priorities: Innovating for the Future, Enhancing Access, Safeguarding ... PARK, Ill., April 27 Abbott today announced the ... "Advancing Innovation." The report provides an update ... on the company,s mission to improve people,s lives around ...
... Argues That Best Opportunity to Maximize Shareholder Value Is ... 27 Anchor Capital, a stockholder of ... that it has sent a letter to the Board ... that BioScrip,s shareholder value would be maximized through simultaneous ...
... , The Ford Fusion Hybrid team has achieved ... gas, raising funds for the Juvenile Diabetes Research Foundation , , ... Passing the 1,000 mile mark at 9:08 a.m. this morning, the team will continue ... remaining , , , , ...
Cached Medicine News:Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 2Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 3Health News:New Campaign Helps Americans Deal With Stressful Times 2Health News:New Campaign Helps Americans Deal With Stressful Times 3Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 2Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 3Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 2Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 2Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 4Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 5Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 6Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 7Health News:One Thousand Miles and Counting: Fusion Hybrid Breaks 1,000 Miles on Single Tank, Presses on 2Health News:One Thousand Miles and Counting: Fusion Hybrid Breaks 1,000 Miles on Single Tank, Presses on 3
(Date:7/28/2014)... Germany und LONDON ... , Ziel der Zusammenarbeit sind ... genomischer Daten aus Plasmaproben zur Steuerung von Therapien ... werden kann  Neuer Bluttest basiert auf ... und soll auf Rotor-Gene Q, einer Automationsplattform der ...
(Date:7/25/2014)... , July 25, 2014  Corporate libraries are constantly ... new advancements in technology and how to cope with ... in the pharmaceutical and medical device industries are increasingly ... information and services they provide. According ... there are many forces of change that leading corporate ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7Forces of Change Reshaping Corporate Libraries & Information Services 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte...
... Based on the original MS-III ... electrosurgery certification, enhanced keypad ... ,The MiniStim® MS-IV peripheral ... for neuromuscular monitoring in operating ...
... is a super-light polypropylene mesh which offers ... is reduced considerably. Optilene Mesh LP is ... hernia repair procedures. It perfectly conforms,to anatomical ... Mesh LP adapts to the movements of ...
... a mesh plug to treat large or ... hernias and femoralhernias. The self-expanding plug perfectly ... completely. Premilene Mesh Self-Forming Plug is a ... Mesh. The plug corresponds with all properties ...
Medicine Products: